Brief: PhaseBio Pharmaceuticals Says Entered Into Supply Agreement With BioVectra

PhaseBio Pharmaceuticals

11/03/2021 13:17

March 11 (Reuters) - PhaseBio Pharmaceuticals Inc  PHAS.O :
    * PHASEBIO PHARMACEUTICALS AND BIOVECTRA ENTER INTO SUPPLY
AGREEMENT TO SUPPORT DEVELOPMENT AND COMMERCIALIZATION OF
BENTRACIMAB
    * PHASEBIO PHARMACEUTICALS - BIOVECTRA WILL PROVIDE ITS
INTEGRATED
CDMO SERVICES FOR MANUFACTURING OF ACTIVE PHARMACEUTICAL
INGREDIENT OF BENTRACIMAB
    * PHASEBIO - CO PLANS TO INTEGRATE API MANUFACTURED AT
COMMERCIAL
SCALE AT BIOVECTRA INTO ONGOING PHASE 2B, PHASE 3 REVERSE-IT
CLINICAL TRIALS
    * PHASEBIO - PENDING APPROVAL OF DRUG, PARTNERSHIP WILL
ENABLE CO
TO SUPPLY BENTRACIMAB AT LAUNCH IN U.S. TO KEY TRAUMA AND
CRITICAL CARE CENTERS

Source text for Eikon:  ID:nBw4GTXjba 
Further company coverage:  PHAS.O 

 ((Reuters.Briefs@thomsonreuters.com;))